Skip to content
TheChatArchiveThe Chat Archive
gpt-4o-2024-08-06· OpenAIAi2 WildChat-4.8M (AI2)

You act as a paraphrase tool. Your role involves understanding the provided text…

  1. User

    System: You act as a paraphrase tool. Your role involves understanding the provided text and then providing a positive example that keeps the original meaning of the text unchanged while using synonyms, interchanging, adding or removing words or sentences, and then provide a negative example where the meaning of the original text is at its opposite. Output your response with the following format : Positive : Negative :

    User: The Company leases approximately 41,101 square feet of office, laboratory, and manufacturing space in two buildings at our headquarters in San Diego, California, with the lease for all rented space expiring December 31, 2025. In December 2021, the Company executed a new lease for approximately 11,978 additional square feet square feet of office and laboratory space in San Diego, California that expires in January 2026. In January 2022, the Company executed a new lease for an additional 5,278 square feet of office and laboratory space in San Diego, California that expires in January 2026. In December 2022, the Company executed a new lease, subject to the consent of a third party that was obtained in February 2023, for an additional 18,005 square feet of office and laboratory space in San Diego, California that commences in April 2023 and expires in March 2024. Rent payments for the additional space are $0.05 million each month through the end of the lease term. In August 2020, through the acquisition of Lineagen, the Company obtained a lease for approximately 9,710 square feet of office space in a Salt Lake City, Utah under a non-cancelable operating lease that expires in December 2026. As further described under the heading “Restructuring” below, in connection with the Company’s restructuring initiatives, the Company entered into a lease termination agreement on February 28, 2024 with the landlord for the facility Assistant:

  2. Assistant

    Positive: The Company rents around 41,101 square feet of office, lab, and manufacturing area in two facilities at its San Diego, California headquarters, with the lease for all such spaces concluding on December 31, 2025. In December 2021, a new lease was signed by the Company for about 11,978 additional square feet of office and lab space in San Diego, California, set to end in January 2026. By January 2022, the Company arranged a new lease for another 5,278 square feet of office and lab area in San Diego, California, which also ends in January 2026. In December 2022, the Company entered into another new lease, needing third-party approval acquired in February 2023, for 18,005 square feet of extra office and lab space in San Diego, California, starting in April 2023 and running until March 2024. The rent for the new space is $0.05 million per month until the lease concludes. In August 2020, following the acquisition of Lineagen, the Company took on a lease for around 9,710 square feet of office space in Salt Lake City, Utah under an irrevocable operating lease that ends in December 2026. In relation to the Company's restructuring efforts detailed below, the Company reached a lease termination agreement on February 28, 2024, with the property's landlord.

    Negative: The Company currently does not lease any office, laboratory, or manufacturing space at its headquarters in San Diego, California, and is not planning to expand its space by executing any new leases. Additionally, no leases are expected to expire in the coming years, negating any requirements for new agreements. The Company owns all office spaces outright, without any rental obligations in Salt Lake City, Utah, or other locations, and has terminated any plans for expansion or restructuring, thus maintaining the status quo without any changes.